Austar Lifesciences Limited (HKG:6118)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8100
+0.0900 (12.50%)
At close: Mar 27, 2026
Market Cap415.19M +2.5%
Revenue (ttm)1.70B +2.0%
Net Income37.62M +110.2%
EPS0.07 +110.2%
Shares Out512.58M
PE Ratio11.04
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,954,000
Average Volume191,900
Open0.7000
Previous Close0.7200
Day's Range0.7000 - 0.9700
52-Week Range0.6500 - 1.9700
Beta1.21
RSI57.38
Earnings DateMar 26, 2026

About Austar Lifesciences

Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. It also offers clean utility and bioprocess equipment, clean room, automation control and monitor system; bioprocess equipment consumab... [Read more]

Sector Healthcare
Founded 1991
Employees 1,446
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6118
Full Company Profile

Financial Performance

In 2025, Austar Lifesciences's revenue was 1.53 billion, an increase of 2.02% compared to the previous year's 1.50 billion. Earnings were 33.81 million, an increase of 110.24%.

Financial numbers in CNY Financial Statements